Lisata Therapeutics, Inc. (LSTA) vs Phio Pharmaceuticals Corp. (PHIO)
A side-by-side comparison of Lisata Therapeutics, Inc. and Phio Pharmaceuticals Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LSTA
Lisata Therapeutics, Inc.
$1.17HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
PHIO
Phio Pharmaceuticals Corp.
$0.99HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
Total return — LSTA vs PHIO
growth of $100 · dividends reinvested · last 10yLSTA -98.2% (-32.9%/yr)PHIO -100.0% (-68.7%/yr)LSTA compounded faster over this window
Log scale — wide-divergence pair
LSTA PHIO
LSTA vs PHIO: by the numbers
- •PHIO is the larger company ($11M vs $11M market cap).
- •Both run net losses; PHIO's is the smaller (0.00% vs -14621.00% net margin).
Metrics side by side
Valuation
| Metric | LSTA | PHIO |
|---|---|---|
| P/S ratio | 106.54 | N/A |
| P/B ratio | 1.29 | 0.91 |
Profitability
| Metric | LSTA | PHIO |
|---|---|---|
| Gross margin | 14.12% | 0.00% |
| Operating margin | -10711.18% | 0.00% |
| Net margin | -14621.00% | 0.00% |
| ROE | -177.35% | -102.40% |
| ROIC | -204.32% | -100.51% |
Growth (annualized)
| Metric | LSTA | PHIO |
|---|---|---|
| Total return CAGR (5Y) | -40.75% | -65.73% |
Frequently asked
- How have LSTA and PHIO total returns compared?
- Over the past 10 years, LSTA delivered -32.84% and PHIO delivered -68.44% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.